Steven Innaimo

Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus

Steven Innaimo, Maria Seifer, Gregory S. Bisacchi et al. · Antimicrobial Agents and Chemotherapy · 1997 · 273 citations · Full text

Hbv Replication, Viral Hepatitis, Mitochondrial Dna Content +14

BMS-200475, a novel carbocyclic 2′-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitro

Gregory S. Bisacchi, Sam Chao, C. Bachard et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 141 citations

Viral Hepatitis, Drug Discovery, Medicine +8

Efficacy of the Carbocyclic 2′-Deoxyguanosine Nucleoside BMS-200475 in the Woodchuck Model of Hepatitis B Virus Infection

Eugene V. Genovesi, L. Lamb, I Medina et al. · Antimicrobial Agents and Chemotherapy · 1998 · 118 citations · Full text

Bms-200475 Therapy, Viral Diagnostics, Hepatitis B +17

Metabolic Studies on BMS-200475, a New Antiviral Compound Active against Hepatitis B Virus

Gregory Yamanaka, T. P. Wilson, Steven Innaimo et al. · Antimicrobial Agents and Chemotherapy · 1999 · 106 citations · Full text

Antiviral Drug, Hepatitis B Virus, Viral Hepatitis +18

Antiviral efficacy of lobucavir (BMS-180194), a cyclobutyl-guanosine nucleoside analogue, in the woodchuck (Marmota monax) model of chronic hepatitis B virus (HBV) infection

Eugene V. Genovesi, L. Lamb, I Medina et al. · Antiviral Research · 2000 · 14 citations

Viral Hepatitis, Medicine, Antiviral Drug Development +10